Related Experiment Video
Updated: Mar 25, 2026
09:15
Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
Published on: May 7, 2019
17.3K
Recurrent IgA Nephropathy After Kidney Transplantation
Melanie L Wyld1, Steven J Chadban
11 Department of Renal Medicine and Transplantation, Royal Prince Alfred Hospital, Sydney, Australia. 2 Kidney Node, Charles Perkins Centre, Sydney Medical School, University of Sydney, Sydney, Australia. 3 Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, Adelaide, Australia.
Transplantation
|February 20, 2016
Summary
Recurrent IgA nephropathy is a risk for kidney transplant recipients. This review covers its epidemiology, diagnosis, outcomes, and management strategies for better patient care.
Area of Science:
- Nephrology
- Transplantation Immunology
- Kidney Disease Epidemiology
Background:
- Immunoglobulin A (IgA) nephropathy is a leading cause of end-stage kidney disease.
- Kidney transplantation is a common treatment for IgA nephropathy.
- Recurrence of IgA nephropathy in the transplanted kidney graft is a significant clinical concern.
Purpose of the Study:
- To provide a comprehensive review of recurrent IgA nephropathy in kidney transplant recipients.
- To discuss the epidemiology, diagnosis, and outcomes of this condition.
- To explore mechanistic insights, therapeutic options, and identify knowledge gaps for future research and improved management.
Main Methods:
- Literature review of epidemiological data.
- Analysis of diagnostic criteria and clinical presentation.
- Review of outcomes and prognostic factors.
- Synthesis of current understanding of disease mechanisms and therapeutic interventions.
Main Results:
- Recurrent IgA nephropathy affects a notable proportion of kidney transplant recipients.
- Early diagnosis and appropriate management can influence graft survival.
- Understanding the underlying mechanisms is crucial for developing targeted therapies.
Conclusions:
- Recurrent IgA nephropathy poses a significant threat to long-term kidney graft survival.
- Further research is needed to elucidate disease mechanisms and optimize treatment strategies.
- Multidisciplinary management is essential for patients at risk of recurrent IgA nephropathy.
Related Concept Videos
01:26Kidney Transplant II: Surgical Procedure
763
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
763
01:16Kidney Transplant III: Nursing Management
556
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
556
01:29Acute Kidney Injury III: Clinical Manifestations
1.4K
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.4K
01:28Kidney Transplant I: Introduction
681
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
681
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
469
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
469
01:29Acute Kidney Injury II: Pathophysiology
1.8K
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.8K